Chemistry: molecular biology and microbiology – Measuring or testing process involving enzymes or...
Reexamination Certificate
2011-03-08
2011-03-08
Aeder, Sean E (Department: 1642)
Chemistry: molecular biology and microbiology
Measuring or testing process involving enzymes or...
Reexamination Certificate
active
07901878
ABSTRACT:
Provided are screening assays for identifying and evaluating compounds with antioxidant and/or antiproliferative activities.
REFERENCES:
patent: 5204354 (1993-04-01), Chakravarty et al.
patent: 5250558 (1993-10-01), Chakravarty et al.
patent: 5407916 (1995-04-01), Wise et al.
patent: 6180082 (2001-01-01), Woltering et al.
patent: 6194386 (2001-02-01), Mertens et al.
patent: 6312661 (2001-11-01), Reubi
patent: 6630123 (2003-10-01), Woltering et al.
patent: 2006/0062729 (2006-03-01), Carraway
Carraway et al (The Journal of Pharmacology and Experimental Therapeutics, 2004, 309(1): 92-101).
Gully et al (The Journal of Pharmacology and Experimental Therapeutics, 1997, 280(2): 802-812).
Rauen et al (J Faseb, 2000, 14:1953-1964).
Adak et al., “Mechanism of horseradish peroxidase catalyzed epinephrine oxidation: obligatory role of endogenous O2−and H2O2,” Biochemistry, 37:16922-33 (1998).
Babior et al., “Biological defense mechanisms. The production by leukocytes of superoxide, a potential bactericidal agent,” J. Clin. Invest., 52:741-744 (1973).
Bartolini et al., “Retinoids and cancer: antitumor effect of ATRA and of a new derivative of retinoic acid, IIF, on colon carcinoma cell lines CaCo-2 and HT-29,” Anticancer Res., 24:1779-83 (2004).
Bass et al., “Flow cytometric studies of oxidative product formation by neutrophils: a graded response to membrane stimulation,” J. Immunol., 130:1910-17 (1983).
Beaudet et al., “Internalization and intracellular mobilization of neurotensin in neuronal cells,” Biochem. Pharmacol., 47:43-52 (1994).
Boudin et al., “Immunological recognition of different forms of the neurotensin receptor in transfected cells and rat brain,” Biochem. J., 305:277-283 (1995).
Boveris A., “Determination of the production of superoxide radicals and hydrogen peroxide in mitochondria,” Methods Enzymol., 105:429-435 (1984).
Brash, “Lipoxygenases: occurrence, functions, catalysis, and acquisition of substrate,” J. Biol. Chem., 274:23679-82 (1999).
Carraway and Leeman, “Radioimmunoassay for neurotensin, a hypothalamic peptide,” J. Biol. Chem., 251:7035-44 (1976).
Carraway and Leeman, “Structural requirements for the biological activity of neurotensin, a new vasoactive peptide,” inPeptides: Chemistry, Structure and Biology, Ann Arbor Science, pp. 679-685 (1975).
Carraway et al., “Ca2+channel blockers enhance neurotensin (NT) binding and inhibit NT-induced inositol phosphate formation in prostate cancer PC3 cells,” J. Pharmacol. Exp. Ther., 307:640-650 (2003).
Carraway et al., “Effects of GTP analogs and metal ions on the binding of neurotensin to porcine brain membranes,” Peptides, 14:37-45 (1993).
Carraway et al., “Polyphenolic antioxidants mimic the effects of 1,4-dihydropyridines on neurotensin receptor function in PC3 cells,” J. Pharmacol. Exp. Ther., 309:92-101 (2004).
Carraway, et al. “Regulation of neurotensin receptor function by the arachidonic acid-lipoxygenase pathway in prostate cancer PC3 cells,” Prostaglandins Leukot. Essent. Fatty Acids, 74:93-107 (2006).
Carraway and Hassan, “Neurotensin receptor binding and neurotensin-induced growth signaling in prostate cancer PC3 cells are sensitive to metabolic stress,” Reg. Pept., 141:140-153 (2007).
Carraway and Hassan, “Protein kinase C inhibitors alter neurotensin receptor binding and function in prostate cancer PC3 cells,” Reg. Pept., 147:96-709(2008).
Casagrande and Darbon, “Effects of structurally related flavonoids on cell cycle progression of human melanoma cells: regulation of cyclin-dependent kinases CDK2 and CDK1,” Biochem. Pharmacol., 61:1205-15 (2001).
Cochrane et al., “Mast cell histamine-releasing activity from stimulated rat neutrophils,” Int. Arch. Allergy Appl. Immunol., 87:269-74 (1988).
Couder et al., “Synthesis and biological activities of psi (CH2NH) pseudopeptide analogues of the C-terminal hexapeptide of neurotensin,” Int. J. Pept. Protein Res., 41:181-84 (1993).
Da Rocha et al., “Targeting protein kinase C: new therapeutic opportunities against high-grade malignant gliomas?” Oncologist, 7:17-33 (2002).
Diaz-Araya et al., “Antioxidant effects of 1,4-dihydropyridine and nitroso aryl derivatives on the Fe+3/ascorbate-stimulated lipid peroxidation in rat brain slices,” Gen. Pharmacol., 31:385-91 (1998).
Egli et al., “Organometallic99mTc-aquaion labels peptide to an unprecedented high specific activity,” J. Nucl. Med., 40:1913-17 (1999).
Elek et al., “Relevant genomics of neurotensin receptor in cancer,” Anticancer Res., 20:53-58 (2000).
Faulkner and Fridovich, “Luminol and lucigenin as detectors for O2 -,” Free Radic. Biol. Med., 15:447-451 (1993).
Ferriola et al., “Protein kinase C inhibition by plant flavonoids: Kinetic mechanisms and structure-activity relationships,” Biochem. Pharmacol., 38:1617-24 (1989).
Fischman et al., “A ticket to ride: peptide radiopharmaceuticals,” J. Nucl. Med., 34:2253-63 (1993).
Fishman et al., “An agonist to the A3 adenosine receptor inhibits colon carcinoma growth in mice via modulation of GSK-3beta and NF-kappa B,” Oncogene, 23:2465-2471 (2004).
Friry et al., “Production of recombinant large proneurotensin
euromedin N-derived peptides and characterization of their binding and biological activity,” Biochem. Biophys. Res. Commun., 290:1161-68 (2002).
Garcia-Garayoa et al., “Preclinical evaluation of a new, stabilized neurotensin(8-13) pseudopeptide radiolabeled with99mTc,” J. Nucl. Med., 43:374-383 (2002).
Gopalakrishna and Gundimeda, “Antioxidant regulation of protein kinase C in cancer prevention,” J. Nutr., 132:3819S-23S (2002).
Gopalakrishna and Jaken, “Protein kinase C signaling and oxidative stress,” Free Rad. Biol. Med., 28:1349-61 (2000).
Granier et al., “Synthesis and characterization of neurotensin analogues for structure/activity relationship studies: Acetyl-neurotensin-(8-13) is the shortest analogue with full binding and pharmacological activities,” Eur J. Biochem., 124: 117-124 (1982).
Guha et al., “Neurotensin induces protein kinase C-dependent protein kinase D activation and DNA synthesis in human pancreatic carcinoma cell line PANC-1,” Cancer Res., 62:1632-40 (2002).
Gully et al., “Biochemical and pharmacological activities of SR 142948A, a new potent neurotensin receptor antagonist,” J. Pharmacol. Exper. Therap., 280:802-812 (1997).
Gully et al., “Biochemical and pharmacological profile of a potent and selective nonpeptide antagonist of the neurotensin receptor,” Proc. Natl. Acad. Sci. USA, 90:65-69 (1993).
Hasegawa et al., “1-Methyl-4-phenylpyridinium (MPP+) induces NADH-dependent superoxide formation and enhances NADH-dependent lipid peroxidation in bovine heart submitochondrial particles,” Biochem. Biophys. Res. Commun., 170:1049-1055 (1990).
Hassan et al., “Involvement of MAP-kinase, PI3-kinase and EGF-receptor in the stimulatory effect of Neurotensin on DNA synthesis in PC3 cells,” Regul. Pept., 120:155-166 (2004).
Hassan and Carraway, “Involvement of arachidonic acid metabolism and EGF receptor in neurotensin-induced prostate cancer PC3 cell growth,” Regul. Pept., 133:105-114 (2006).
Hendriks et al., “Flavonoids inhibit myelin phagocytosis by macrophages; a structure-activity relationship study,” Biochem. Pharmacol., 65:877-885 (2003).
Huang et al., “Effects of luteolin and quercetin, inhibitors of tyrosine kinase, on cell growth and metastasis-associated properties in A431 cells overexpressing epidermal growth factor receptor,” Br. J. Pharmacol., 128:999-1010 (1999).
Hyslop and Sklar, “A quantitative fluorimetric assay for the determination of oxidant production by polymorphonuclear
Aeder Sean E
Fish & Richardson P.C.
University of Massachusetts
LandOfFree
Screening assays for antioxidants and antiproliferative... does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Screening assays for antioxidants and antiproliferative..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Screening assays for antioxidants and antiproliferative... will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-2713162